BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29884414)

  • 1. A clinical prognostic model compared to the newly adopted UICC staging in an independent validation cohort of P16 negative/positive head and neck cancer patients.
    Rasmussen JH; Håkansson K; Rasmussen GB; Vogelius IR; Friborg J; Fischer BM; Bentzen SM; Specht L
    Oral Oncol; 2018 Jun; 81():52-60. PubMed ID: 29884414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual.
    Beltz A; Gösswein D; Zimmer S; Limburg I; Wünsch D; Gribko A; Deichelbohrer M; Hagemann J; Stauber RH; Künzel J
    Eur J Surg Oncol; 2019 Jun; 45(6):1046-1053. PubMed ID: 30857877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
    Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
    Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of Unknown Primary and the 8th Edition TNM Classification for Head and Neck Cancer.
    Boeker R; Stromberger C; Heiland M; Beck-Broichsitter B; Hofmann VM; Neumann K; Ochsenreither S; Olze H; Dommerich S; Piwonski I; Coordes A
    Laryngoscope; 2021 Sep; 131(9):E2534-E2542. PubMed ID: 33734438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma.
    Würdemann N; Wagner S; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wittekindt C
    Front Oncol; 2017; 7():129. PubMed ID: 28713770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams).
    Grønhøj C; Jensen DH; Dehlendorff C; Marklund L; Wagner S; Mehanna H; Munck-Wikland E; Ramqvist T; Näsman A; Wittekindt C; Würdemann N; Sharma SJ; Gattenlöhner S; Kiss K; Andersen E; Spruce R; Batis N; Robinson M; Harrington K; Winter S; Jones TM; Klussmann JP; Dalianis T; Friborg J; von Buchwald C
    Br J Cancer; 2018 Jun; 118(12):1672-1681. PubMed ID: 29795309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection.
    Yamashita Y; Ikegami T; Hirakawa H; Uehara T; Deng Z; Agena S; Uezato J; Kondo S; Kiyuna A; Maeda H; Suzuki M; Ganaha A
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):827-836. PubMed ID: 30594962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
    Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the UICC 8th edition staging of oral cavity squamous cell carcinoma in a UK cohort.
    McGoldrick DM; Torres-Rendon A; Sandhu R; Walton G
    Br J Oral Maxillofac Surg; 2021 Jan; 59(1):76-81. PubMed ID: 33082012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity and irregularity of pretreatment
    Cheng NM; Fang YD; Tsan DL; Lee LY; Chang JT; Wang HM; Ng SH; Liao CT; Yang LY; Yen TC
    Oral Oncol; 2018 Mar; 78():156-162. PubMed ID: 29496044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival prediction for oropharyngeal cancer beyond TNMv8.
    Price JM; West CM; Mistry HB; Betts G; Bishop P; Kennedy J; Dixon L; Homer JJ; Garcez KP; Lee LW; McPartlin A; Sykes AJ; Thomson DJ
    Oral Oncol; 2021 Apr; 115():105140. PubMed ID: 33548862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancer.
    Farquhar DR; Coniglio AJ; Masood MM; Lenze N; Brennan P; Anantharaman D; Abedi-Ardekani B; Zanation AM; Weissler MC; Olshan AF; Sheth S; Hackman TG
    Oral Oncol; 2020 Sep; 108():104800. PubMed ID: 32492516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Base of tongue squamous cell carcinomas, outcome depending on treatment strategy and p16 status. A population-based study from the Swedish Head and Neck Cancer Register.
    Högmo A; Holmberg E; Haugen Cange H; Reizenstein J; Wennerberg J; Beran M; Söderkvist K; Hammerlid E; Sjödin H; Farnebo L; Sandström K; Hammarstedt-Nordenvall L; Zborayova K; Brun E
    Acta Oncol; 2022 Apr; 61(4):433-440. PubMed ID: 35081863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Staging of oropharyngeal carcinomas : New TNM classification as a challenge for head and neck cancer centers].
    Beltz A; Gösswein D; Zimmer S; Stauber RH; Hagemann J; Strieth S; Matthias C; Künzel J
    HNO; 2018 May; 66(5):375-382. PubMed ID: 29536123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
    Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K
    AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.